H1N1 Flu Antibodies
Influenza A (H1N1) virus, a subtype of influenza virus A, is the most common cause of influenza in humans. A strain of swine-origin H1N1 was responsible for the 2009 flu pandemic. On April 29th, 2009, the influenza pandemic alert of H1N1 flu was raised from phase 4 to phase 5. Subsequently on June 11th, 2009, the alert progressed to phase 6 as announced by WHO. In response to this severe situation, GenScript will offer whatever resources available to help researchers contain H1N1 virus.
At GenScript, we produce high-quality bio-reagents, including highly sensitive and specific antibodies, genes, peptides, and proteins, in a flexible and timely manner. Specifically, high quality antibodies can be readily employed in the detection of influenza A virus through routine immunoassays (Western blotting). Various epitope antibodies are also available for virus characterization. Please select the H1N1 antibody you would like to place your order!
In addition to high-quality bio-reagents, GenScript offers a variety of services to expedite H1N1 (swine flu) research. Specially, assay development and gene synthesis services are among the most prominent services targeting H1N1 research. We have synthesized many influenza related genes such as HA (GN465626, GN874347, GN883813), NP (GN007602), NA (GN084909, GN078477, GN086250), etc. In particular, HA (Hemagglutinin), an antigenic glycoprotein found on the surface of the H1N1 virus, is responsible for binding the virus to the cell that is being infected.
GenScript offers clients and strategic partners guaranteed satisfaction and special discounts from our economy-of-scale and broadness-of-scope bio-reagent services in molecular biology, custom peptides, custom proteins, custom antibody production, and custom cell line development.
GenScript's reliable biology services are streamlined for efficiency and quality!